HC Wainwright Upgrades Sensei Biotherapeutics (NASDAQ:SNSE) to Buy
Sensei Biotherapeutics (NASDAQ:SNSE – Get Free Report) was upgraded by equities researchers at HC Wainwright to a “buy” rating in a research report issued to clients and investors on Monday, Marketbeat.com reports. The brokerage currently has a $5.00 target price on the stock. A number of other research firms have also issued reports on SNSE. […]
Sensei Biotherapeutics (NASDAQ:SNSE – Get Free Report) was upgraded by equities researchers at HC Wainwright to a “buy” rating in a research report issued to clients and investors on Monday, Marketbeat.com reports. The brokerage currently has a $5.00 target price on the stock. A number of other research firms have also issued reports on SNSE. […]
